RANIMUSTINE for Bone marrow conditioning regimen: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 17 adverse event reports in the FDA FAERS database where RANIMUSTINE was used for Bone marrow conditioning regimen.
Most Reported Side Effects for RANIMUSTINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Febrile neutropenia | 25 | 11.4% | 8 | 7 |
| Drug ineffective | 24 | 10.9% | 7 | 10 |
| Haemolytic anaemia | 16 | 7.3% | 0 | 15 |
| Thrombotic microangiopathy | 16 | 7.3% | 0 | 15 |
| Hepatitis b | 14 | 6.4% | 2 | 0 |
| Hypoxia | 14 | 6.4% | 0 | 11 |
| Ventricular hypokinesia | 14 | 6.4% | 0 | 13 |
| Acute kidney injury | 13 | 5.9% | 0 | 11 |
| Bone marrow failure | 12 | 5.5% | 1 | 5 |
| Cardiac failure | 12 | 5.5% | 0 | 11 |
| Renal impairment | 12 | 5.5% | 1 | 2 |
| Acute myeloid leukaemia | 11 | 5.0% | 9 | 1 |
| Hypertension | 11 | 5.0% | 0 | 8 |
| Myelodysplastic syndrome | 11 | 5.0% | 0 | 0 |
| Myelosuppression | 11 | 5.0% | 0 | 8 |
Other Indications for RANIMUSTINE
Adult t-cell lymphoma/leukaemia (55)
Diffuse large b-cell lymphoma (39)
Plasma cell myeloma (13)
Central nervous system lymphoma (10)
Product used for unknown indication (8)
Hodgkin's disease (7)
Non-hodgkin's lymphoma (7)
Lymphoma (5)
Other Drugs Used for Bone marrow conditioning regimen
FLUDARABINE (6,080)
BUSULFAN (4,669)
CYCLOPHOSPHAMIDE (4,485)
MELPHALAN (2,368)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (1,884)
THIOTEPA (1,551)
ALEMTUZUMAB (1,122)
ETOPOSIDE (936)
CYTARABINE (833)
THYMOCYTE IMMUNE GLOBULIN NOS (742)